FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients

Aug 25 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it authorized Abbott Laboratories' glucose monitor, ...

FDA approves Abbott's first wearable device for dual ketone and glucose tracking

The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories’ ABT Libre Duo 10 Day Continuous Dual ...
Medical Device and Diagnostic Industry (MD+DI)

Abbott Wins FDA Nod for World's First Dual Glucose-Ketone Sensor

Abbott's Libre Duo 10 Day wins FDA authorization as the first CGM to monitor both glucose and ketones, helping prevent ...

First dual glucose-ketone tracker on the way for diabetes patients

Diabetes patients' lives could be about to get safer following the granting of regulatory approval for a world-first wearable monitor combining glucose and ketone tracking for warnings ahead of ...
24/7 Wall St.

The FDA Just Gave Abbott a Diabetes First. Is Its Beaten-Down Stock Ready to Wake Up?

Abbott just scored a regulatory first in diabetes care that no rival has matched, yet the stock sits well below where it ...

What Does Abbott Laboratories (ABT) FDA Clearance Mean For Its Diabetes Device Push?

Abbott Laboratories (NYSE:ABT) received FDA De Novo authorization for its Libre Duo 10 Day, described as the first dual ...

Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes

Abbott (NYSE: ABT), the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) authorization of its Libre Duo 10 Day system, the world's first dual glucose‑ketone sensing ...
MD&M East

Abbott Is Becoming the Most Sought-After Partner in Diabetes Tech

Abbott Laboratories isn’t one to shy away from collaborations in the diabetes space. After all, the Abbott Park, IL-based company teamed up with rival Medtronic to develop a continuous glucose ...
Nasdaq

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

Diabetic ketoacidosis (DKA) can develop quickly and is not always easy to detect early Ketone monitoring is not yet routine in diabetes care, which may contribute to missed warning signs of DKA and ...
MM&M

Abbott confronts diabetes stigma with Above the Bias spot

For a disease that affects more than 30 million Americans, diabetes still has a lingering stigma related to the belief that it’s the result of poor lifestyle choices or lack of self control. That’s a ...
MM&M

Laughing through diabetes: Sherri Shepherd joins Abbott’s awareness installation

Abbott has rolled out an installation at the Oculus Center in New York City for National Diabetes Awareness Month, highlighting patient stories focused on diabetes. The installation — which will also ...